Prof. Ichiro Kurokawa

Meiwa Hospital, Japan

Email: [email protected]

Qualifications

1988 Ph.D., Kansai Medical university, Japan

1983 M.Sc., Kansai Medical University, Japan

Publications (Selected)

1. Alexis, A., Tan, J., Rocha, M., Kerob, D., Ly, F., Wu, Y., ... & Kurokawa, I. (2024). Is Acne the Same Around the World?. The Journal of Clinical and Aesthetic Dermatology, 17(9), 16.
2. Thiboutot D, Layton AM, Traore I, Gontijo G, Troielli P, Ju Q, Kurokawa I, Dreno B. International expert consensus recommendations for the use of dermocosmetics in acne. Journal of the European Academy of Dermatology and Venereology. 2024.
3. Kurokawa I, Kita K, Hashimoto T. Successful treatment of ulceration in hidradenitis suppurativa with topical bucladesine: A case report. Skin Health and Disease. 2024 Feb;4(1):e321.
4. Kurokawa I, Kobayashi M, Nomura Y, Abe M, Kerob D, Dreno B. The role and benefits of dermocosmetics in acne management in japan. Dermatology and Therapy. 2023 Jul;13(7):1423-33.
5. Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T. Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52‐week analysis of a postmarketing surveillance study in Japan. The Journal of Dermatology. 2023 Aug;50(8):1034-44.
6. Kita K, Kurokawa I, Hayashi D, Hashimoto T. Prurigo pigmentosa clinically and immunologically mimicking autoimmune bullous disease: A case report. Frontiers in Medicine. 2022 Dec 2;9:1047870.
7. Kurokawa I, Kanayama S, Yamasaki O. Antimicrobial activity of ozenoxacin and other antimicrobials against Staphylococcus aureus strains isolated from clinical skin specimens in Japan in 2019 and 2020. Journal of Infection and Chemotherapy. 2022 Dec 1;28(12):1693-6.
8. Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T. Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12‐week interim analysis of post‐marketing surveillance in Japan. The Journal of Dermatology. 2022 Apr;49(4):411-21.
9. Nogita T, Nomura Y, Kurokawa I. Postinflammatory Papule: A Tentative New Designation for Acne Vulgaris. Dermatology and Therapy. 2021 Dec;11(6):1867-9.
10. Kurokawa I, Layton AM, Ogawa R. Updated treatment for acne: targeted therapy based on pathogenesis. Dermatology and therapy. 2021 Aug;11(4):1129-39.
11. Chandran NS, Lee JH, Kurokawa I. Hidradenitis suppurativa in South‐East Asia and East Asia. Experimental Dermatology. 2021 Jun;30:23-6.
12. Kurokawa I. Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab. The Journal of Dermatology. 2021 May 7;48(8):e374-5.
13. Kurokawa I, Yoshioka M, Ito S. Split-face comparative clinical trial using glyceryl-octyl-ascorbic acid/ascorbyl 2-phosphate 6-palmitate/DL-α-tocopherol phosphate complex treatment for postinflammatory hyperpigmentation, postinflammatory erythema and atrophic scar in acne vulgaris. The Journal of dermatology. 2019 Oct;46(10):e347-8.
14. Kurokawa I. Perifolliculitis capitis abscedens et suffodiens successfully treated with Saireito. The Journal of dermatology. 2019 Aug;46(8):e299-301.
15. Hayashi N, Kurokawa I, Siakpere O, Endo A, Hatanaka T, Yamada M, Kawashima M. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed‐dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator‐blind, parallel‐group study. The Journal of dermatology. 2018 Aug;45(8):951-62.
16. Hayashi N, Akamatsu H, Iwatsuki K, Shimada‐Omori R, Kaminaka C, Kurokawa I, Kono T, Kobayashi M, Tanioka M, Furukawa F, Furumura M. Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017. The Journal of dermatology. 2018 Aug;45(8):898-935.
17. Kurokawa I. Non-surgical treatment with basic fibroblast growth factor for atrophic scars in acne vulgaris. The Journal of dermatology. 2018 Sep;45(9):e238-9.
18. Watanabe S, Ohnishi T, Yuasa A, Kiyota H, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Manabe M, Suzuki T. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. Journal of Infection and Chemotherapy. 2017 Aug 1;23(8):503-11.
19. Kurokawa I, Kakuno A, Tsubura A. Milia may originate from the outermost layers of the hair bulge of the outer root sheath: A case report. Oncology Letters. 2016 Dec 1;12(6):5190-2.
20. Kurokawa I, Oiso N, Kawada A. Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non‐inflamed atrophic scars in acne vulgaris. The Journal of Dermatology. 2017 Apr;44(4):401-5.
21. Zouboulis CC, Picardo M, Ju Q, Kurokawa I, Törőcsik D, Bíró T, Schneider MR. Beyond acne: Current aspects of sebaceous gland biology and function. Reviews in Endocrine and Metabolic Disorders. 2016 Sep;17:319-34.
22. Ueda M, Yasuda M, Shibaoka Y, Kurokawa I, Kakuno A, Tsubura A. Keratin 19‑positive cutaneous squamous cell carcinoma with elevated serum cytokeratin 19 fragment 21-1 level: A case report. Molecular and Clinical Oncology. 2016 Jun 1;4(6):986-8.
23. Yuki M, Yoshizawa K, Emoto Y, Yuri T, Kinoshita Y, Tsubura A, Kurokawa I. Cutaneous epithelial lesions induced by N-methyl-N-nitrosourea in male Sprague-Dawley rats: a possible animal model for human keratoacanthoma. Anticancer Research. 2016 Jan 1;36(1):111-20.
24. Kurokawa I. Case reports of adjuvant combination therapy in severe acne vulgaris with chemical peeling using glycolic acid and iontophoresis. The Journal of Dermatology. 2015 Aug 6;42(11):1120-1.

Profile Details

https://www.walshmedicalmedia.com/author-profile/ichiro-kurokawa-313970

https://www.webofscience.com/wos/author/record/1287039

https://pubmed.ncbi.nlm.nih.gov/?cmd=search&term=Ichiro+Kurokawa